Product Images Sildenafil Citrate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Sildenafil Citrate NDC 51655-794 by Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - 51655 794 54 Master Bottle Label Approval Rev A 01 22
Sildenafil is a medication presented in 15 tablets per package with a dosage of 100 mg. It contains citrate USP equivalent to 100mg of sidenafil. It is a prescription drug, so patients should follow the package insert instructions. The tablets should be stored in a container at a temperature ranging between 20°-25°C (68°-77°F). The tablets are film-coated and repackaged from 13668-188-XX by Torrent Pharma Inc. and repackaged by Northwind Pharmaceuticals in Indianapolis. The product's GTIN is 0035165794548, and the S/N is 000000000000000. The expiration date is programmed to be 00/00/0000, and the lot number should be 0000000000. Lastly, it is not advised to be kept near children.*
chemical-structure - chemical structure
figure-1 - figure 1
The text appears to be a graph showing the systolic blood pressure in mmHg at different time intervals after taking Sildenafil 100mg or placebo. The blood pressure values are shown on the y-axis and the time post-dose is shown on the x-axis. "Pre-Dose" indicates the starting point of the test, "Time post dose" indicates how long after taking the medication the blood pressure was measured. The graph shows that after taking Sildenafil, the systolic blood pressure decreased gradually over time, while the placebo group remained relatively constant.*
figure-2 - figure 2
The text is describing a change in systolic blood pressure (SBP) in millimeters of mercury (mmHg) over time (in hours) after taking either Doxazosin alone with a placebo or Doxazosin combined with Sildenafil 25mg. It shows a graph representing the change in SBP over 7 hours post-dose.*
figure-3 - figure 3
The text describes a chart that shows the change in SBP (Systolic Blood Pressure) expressed in mmHG (millimeters of mercury), with two different treatments named "Doxazosin + Placebo" and "Doxazosin + Sildenafil 50 mg". The chart displays data for time postdose measured in hours up to 8.000.*
figure-4 - figure 4
The text seems to contain only a list of drug names, dosages, and a numerical chart for time after dosing. No useful description can be generated from this text.*
figure-5 - figure 5
This text provides information on plasma concentrations of a commercial tablet at different time points post dose. However, the specifics of the tablet and the substance being tested are not available.*
figure-6-1 - figure 6 1
This is a table with data on the percentage of patients at endpoint and baseline score. It seems to be related to a medical or clinical study, but without additional information, its purpose is not clear.*
figure-6-2 - figure 6 2
figure-7 - figure 7
This data represents the percentage of patients reporting improvement after being treated with varying doses of sildenafil citrate compared to a placebo. The data shows that the highest percentage of patients reporting improvement was in the 100mg group at 63%, followed by the 50mg group at 74%, and the 25mg group at 82%. The placebo group had the lowest percentage of patients reporting improvement at 24%. The total number of patients evaluated in this study was 463 for the placebo and 214, 391, and 380 for the 25mg, 50mg, and 100mg groups respectively.*
torrent-logo - torrent logo
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.